Business / Finance

RSS

Escalon Medical announces operating results for fiscal 2014; VuPad receives CE mark authorization

Escalon Medical Corp. (NASDAQ: ESMC) today announced its operating results for the fiscal year ended September 30, 2014.

27 Sep 2014

Universal Health Services acquires Cygnet Health Care, added as component of S&P 500 Index

Universal Health Services, Inc. announced today that it has acquired the stock of Cygnet Health Care Limited ("Cygnet") for a purchase price of approximately $335 million.

26 Sep 2014

Abbott acquires CFR Pharmaceuticals; declares results of tender offer for CFR's ordinary shares

Abbott has acquired control of CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding the company's presence in fast-growing markets.

26 Sep 2014

Bionow announces its annual life science investment and showcase conference

Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, announces its annual BioCap Conference, which will take place at the Hilton Hotel, Manchester on the 29th September 2014.

26 Sep 2014

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Sumitomo Dainippon Pharma Co., Ltd. and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc., announced on September 26 that the two companies have entered into a joint development and license agreement for exclusive marketing rights in the U.S. and Canada ("Agreement") for SB623, a cell therapy for the treatment of patients with chronic stroke discovered and currently under development by SanBio.

26 Sep 2014

ZirMed announces acquisition of MethodCare

ZirMed, the premier cloud-based enterprise business and clinical performance solution for healthcare, today announced the acquisition of MethodCare, Inc.

25 Sep 2014

Caring Brands International acquires Australia-based Just Better Care

Caring Brands International, which includes Interim HealthCare Inc., a national network of home care, hospice and health staffing franchises founded in 1966 and known for its continuum of care in the United States, today expands its global operations with the acquisition of Australia-based Just Better Care.

25 Sep 2014

CVS/pharmacy renews Medication Disposal for Safer Communities donation program

CVS/pharmacy announced today that is marking National Prescription Drug Take Back Day on Saturday, September 27 by renewing its innovative community donation program to support local drug collection efforts by law enforcement.

25 Sep 2014

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

IGI Laboratories, Inc., a New Jersey based specialty generic pharmaceutical company, today announced it has acquired the regulatory rights and related documents and records for 18 drug products from AstraZeneca, 17 of which were marketed.

25 Sep 2014

INTERTEL joins National Insurance Crime Bureau as strategic partner

The National Insurance Crime Bureau is pleased to announce that INTERTEL, Inc., one of the original providers of Medical Canvass Investigations, has joined the organization as a strategic partner.

25 Sep 2014

IMRIS enters into Waiver and Amendment Agreement with Deerfield Management Company

IMRIS Inc. ("IMRIS" or the "Company") today announced it has entered into a Waiver and Amendment Agreement with Deerfield Management Company, L.P. ("Deerfield") with respect to the Facility Agreement dated as of September 16, 2013.

24 Sep 2014

Abbott announces expiration of the U.S. tender offer for CFR ordinary shares

Abbott today announced the expiration of the tender offer for the purchase from U.S. holders of the ordinary shares of CFR Pharmaceuticals S.A., a Chilean corporation, and for the purchase from all holders, wherever resident, of CFR's outstanding American Depositary Shares.

24 Sep 2014

Leading provider of eClinical solutions, epharmasolutions joins WIRB group of companies

WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies.

24 Sep 2014

AIT, BioVendor and SCIENION partner to develop in-vitro diagnostic test for colon cancer

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.

24 Sep 2014

Celgene Global Health, DNDi expand partnership to identify new drug candidates for NTDs

Celgene Global Health, a division of Celgene Corporation, and the Drugs for Neglected Diseases initiative strengthen their collaboration with a four-year Research Collaboration Agreement to identify and optimize new drug candidates for the treatment of neglected tropical diseases (NTDs).

24 Sep 2014

ImmunoCellular signs licensing agreement with Caltech to develop antigen-specific T-cell technology

ImmunoCellular Therapeutics, Ltd. announced today that it has established a licensing agreement with the California Institute of Technology for exclusive rights to novel technology for the development of certain antigen specific T-cell immunotherapies for the treatment of cancer.

24 Sep 2014

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Avalon Ventures today announced the launch of two new companies formed through its collaboration with GlaxoSmithKline to fund and launch up to 10 early-stage life science companies.

23 Sep 2014

Arthur J. Gallagher & Co. announces acquisition of The Benfield Group

Arthur J. Gallagher & Co. today announced the acquisition of the healthcare consulting firm, The Benfield Group. Headquartered in St. Louis, the firm also has offices in Chicago, Washington, D.C. and Atlanta.

23 Sep 2014

Propanc, Southridge Partners enter into equity purchase agreement

Propanc Health Group Corporation, an emerging healthcare company that focuses on the development of new and proprietary treatments for cancer patients, is pleased to announce it has executed an equity purchase agreement (the "EPA") with Southridge Partners II, L.P., an institutional investor, in the amount of $5 million, which will create significant growth capital for Propanc, enabling the execution of its business plan, on favorable terms.

23 Sep 2014

Neogen's first quarter net income increases 13%

Neogen Corporation announced today that net income for the first quarter of its 2015 fiscal year, which ended Aug. 31, was $8,883,000 — a 13% increase compared to net income of $7,839,000 in the first quarter of last year.

22 Sep 2014

Business / Finance

Escalon Medical announces operating results for fiscal 2014; VuPad receives CE mark authorization

Universal Health Services acquires Cygnet Health Care, added as component of S&P 500 Index

Abbott acquires CFR Pharmaceuticals; declares results of tender offer for CFR's ordinary shares

Bionow announces its annual life science investment and showcase conference

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

ZirMed announces acquisition of MethodCare

Caring Brands International acquires Australia-based Just Better Care

CVS/pharmacy renews Medication Disposal for Safer Communities donation program

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

INTERTEL joins National Insurance Crime Bureau as strategic partner

IMRIS enters into Waiver and Amendment Agreement with Deerfield Management Company

Abbott announces expiration of the U.S. tender offer for CFR ordinary shares

Leading provider of eClinical solutions, epharmasolutions joins WIRB group of companies

AIT, BioVendor and SCIENION partner to develop in-vitro diagnostic test for colon cancer

Celgene Global Health, DNDi expand partnership to identify new drug candidates for NTDs

ImmunoCellular signs licensing agreement with Caltech to develop antigen-specific T-cell technology

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Arthur J. Gallagher & Co. announces acquisition of The Benfield Group

Propanc, Southridge Partners enter into equity purchase agreement

Neogen's first quarter net income increases 13%

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News